Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

FTSE 100 movers: Barratt Developments in top spot, Shell close behind

Housebuilder Barratt Developments clawed back yesterday's losses, claiming its place in the top spot. Oil major Royal Dutch Shell rose strongly as first-quarter underlying earnings fell by 3% but beat expectations. Bottom-line earnings, however, were hit by £2.9bn of impairments in its Downstream

30 Apr 14 14:40

GSK says staying on sidelines in Astra, Pfizer fight

* CEO says just "interested observer" in takeover battle * Witty views broad-based M&A deals as distracting * Sees "rational" case for investing in UK science By Ben Hirschler LONDON, April 30 (Reuters) - GlaxoSmithKline is just an "interested observer" as U.S. drugmaker P

30 Apr 14 14:01

UPDATE: Glaxo Profit Down But Raises Dividend And Keeps Guidance

LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite

30 Apr 14 13:32

UK MIDDAY BRIEFING: Glaxo, Shell Lift Dividends Despite Weak Profits

LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance

30 Apr 14 12:54

UPDATE 1-Poor lung drug sales hit GSK in Q1, CEO wary on M&A

* U.S. Advair sales drop 20 percent, China also weak * CEO says broad-based M&A deals "distracting" * Q1 sales 5.61 bln pounds vs consensus 5.84 bln * Q1 core EPS 21.0 pence vs consensus 20.7p (Adds CEO comments on M&A, shares, analyst reaction) By Ben Hirschler LO

30 Apr 14 12:42

GlaxoSmithKline's first-quarter sales fall short - UPDATE

- Sales down 10 per cent on reported basis - EPS falls 20 per cent - US weakness offsets growth elsewhere - Company changes guidance language The strength of sterling had a big impact on results at GlaxoSmithKline (GSK) in the first quarter, while sales fell short of analysts' expectations due to w

30 Apr 14 12:12

MARKET COMMENT: US Stocks Seen Lower On Earnings, Ahead Of Data

LONDON (Alliance News) - US equities are set to open marginally lower Wednesday, as investors digest the latest tranche of quarterly trading statements released after the Wall Street close on Tuesday, and ahead of some important US macroeconomic data and the latest Federal Open Market Committee p

30 Apr 14 12:04

GLAXOSMITHKLINE CEO SAYS NOT SURE A SINGLE NARRATIVE AROUND SECTOR M&A

GLAXOSMITHKLINE CEO SAYS NOT SURE A SINGLE NARRATIVE AROUND SECTOR M&A GLAXOSMITHKLINE CEO SAYS NO UPDATE ON CHINA INVESTIGATION GLAXOSMITHKLINE CEO SAYS U.S. ADVAIR SHARE FELL IN EARLY JANUARY BUT HAS SINCE STABILISED GLAXOSMITHKLINE CEO SAYS UK HAS "TERRIFIC" SCIENCE BASE AND GREAT SUPPORT FOR

30 Apr 14 11:54

London midday: Stocks rise but markets cautious ahead of Fed decision

- Markets cautious ahead of FOMC outcome - Eurozone inflation picks up but misses consensus - Heritage Oil jumps on takeover offer - Shell and Tullow lead markets higher techMARK 2,775.59 -0.56% FTSE 100 6,776.83 +0.10% FTSE 250 15,813.39 -0.52% UK stocks were trading slightly higher on Wednesday

30 Apr 14 11:53

Glaxo Profit Down, But Raises Dividend Despite Muddying Sales Guidance

LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite

30 Apr 14 11:33

RPT-GlaxoSmithKline drug sales off to weak start in Q1

(Repeats to attach to Reuters alerts) LONDON, April 30 (Reuters) - GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week's decision to trade more than $20 billion of assets with Swiss rival Novartis . Rep

30 Apr 14 11:24

GlaxoSmithKline drug sales off to weak start in Q1

LONDON, April 30 (Reuters) - GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week's decision to trade more than $20 billion of assets with Swiss rival Novartis . Reported sales in the first quarter, which were

30 Apr 14 11:16

UK lawmakers plan to probe Pfizer pursuit of AstraZeneca

By Kylie MacLellan and Ben Hirschler LONDON, April 30 (Reuters) - British lawmakers intend to investigate U.S. drugmaker Pfizer's planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected. Members of the parliamentary busi

30 Apr 14 10:26

GSK Nigerian unit Q1 pretax profit up 3.06 pct to 892.13 mln naira

LAGOS, April 30 (Reuters) - GSK's Nigerian unit on Wednesday posted a first-quarter pretax profit of 892.13 million naira ($5.56 million), up 3.06 percent from 864.83 million a year earlier. Revenue rose to 7.80 billion naira from 6.92 billion, the pharmaceutical and healthcare company sai

30 Apr 14 09:59

MARKET COMMENT: Shell Overtakes BP Amid Mixed London Trading

LONDON (Alliance News) - UK stocks trade mixed Wednesday, as investors await a raft of releases from the US and after the preliminary reading of eurozone consumer price inflation accelerated from a more than four-year low, but still missed forecasts. By mid-morning, the FTSE 100 is marginal

30 Apr 14 09:47

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.